Paul Workman
Institute of Cancer Research · 1,191 works · 47,600 citations · h-index 106
Top works
- Guidelines for the welfare and use of animals in cancer research
- Patient-derived organoids model treatment response of metastatic gastrointestinal cancers
- DT-Diaphorase Expression and Tumor Cell Sensitivity to 17-Allylamino,17-demethoxygeldanamycin, an Inhibitor of Heat Shock Protein 90
- The Identification of 2-(1 H -Indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2- d ]pyrimidine (GDC-0941) as a Potent, Selective, Orally Bioavailable Inhibitor of Class I PI3 Kinase for the Treatment of Cancer
- Imaging biomarker roadmap for cancer studies
- Combinatorial drug therapy for cancer in the post-genomic era
- HSP90 as a new therapeutic target for cancer therapy: the story unfolds
- UKCCCR guidelines for the welfare of animals in experimental neoplasia
- The promise and peril of chemical probes
- Partition Coefficient as a Guide to the Development of Radiosensitizers Which Are Less Toxic Than Misonidazole
- Phase I Pharmacokinetic and Pharmacodynamic Study of 17-Allylamino, 17-Demethoxygeldanamycin in Patients With Advanced Malignancies
- DT-diaphorase and cancer chemotherapy
- The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations
- Anticancer Agents Targeting Signaling Molecules and Cancer Cell Environment: Challenges for Drug Development?
- Targeting the PI3K–AKT–mTOR pathway: progress, pitfalls, and promises
- Activation of the ATPase Activity of Hsp90 by the Stress-Regulated Cochaperone Aha1
- Direct measurement of pO2 distribution and bioreductive enzymes in human malignant brain tumors
- To pop or not to pop: p53 as a critical modulator of tumour responsiveness to therapy in vivo?
- Drugging the Cancer Chaperone HSP90
- New approaches to molecular cancer therapeutics